Menopause in bloom

Industry
By
Natsumi Penberthy
-

References

  1. Rossouw JE, Anderson GL, Prentice RL, et al.; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288(3):321–333.
  2. Manson JE, Aragaki AK, Rossouw JE, et al.; WHI Investigators. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women’s Health Initiative randomized trials. JAMA 2017;318(10):927–938.
  3. Mishra GD, et al. International Collaboration for a Life Course Approach to Reproductive Health and Chronic Disease Events (InterLACE). Brisbane: School of Public Health, University of Queensland. At: https://public-health.uq.edu.au/interlace
  4. NHS Business Services Authority. Hormone replacement therapy – England – April 2015 to June 2023. Newcastle upon Tyne: NHSBSA Statistics and Data Science. 2023.
  5. Risni HW, Brauer R, et al. Trends in government-subsidised menopausal hormone therapy dispensing in Australia between 2014 and 2023. Aust N Z J Obstet Gynaecol 2026;66(2):e70135.
  6. Islam RM, Bond M, Ghalebeigi A, et al. Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women’s Midlife Years (AMY) Study. Lancet Diabetes Endocrinol 2025;13(9):765–776.
  7. Duncan A, Hailemariam A, Salazar S, et al.; Bankwest Curtin Economics Centre. The costs and benefits of implementing a universal reproductive health leave entitlement in Australia. Perth: Curtin University. 2025.
  8. Australasian Menopause Society, Women’s Health Research Program (Monash University), Jean Hailes for Women’s Health. The impact of symptoms attributed to menopause by Australian women: a report from the 2023 National Women’s Health Survey. Melbourne: Jean Hailes for Women’s Health. 2023.
  9. Senate Community Affairs References Committee. Issues related to menopause and perimenopause. Canberra: Parliament of Australia. 2024.
  10. Therapeutic Goods Administration. About the shortage of transdermal HRT patches. Canberra: TGA. 2024. At: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-shortage-transdermal-hrt-patches
  11. Therapeutic Goods Administration. Substitution approval extended for HRT patch shortages. Canberra: TGA. 2026. At: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/medicine-shortage-alerts/substitution-approval-extended-hrt-patch-shortages
  12. Therapeutic Goods Administration. Section 19A approvals database. Canberra: TGA. At: https://www.tga.gov.au/resources/section-19a-approvals
  13. Australasian Menopause Society. AMS guide to MHT/HRT doses – Australia. AMS Hub. At: https://hub.menopause.org.au/Play?pId=6ecead60-db26-4dfc-a662-794d7b39ef59
  14. Therapeutic Goods Administration. About the shortage of transdermal HRT patches: information for prescribers. Canberra: TGA. 2024. At: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-shortage-transdermal-hrt-patches#information-for-prescribers
  15. Australian Government Department of Health and Aged Care. Government response to inquiry – issues related to menopause and perimenopause. Canberra: Australian Government. 2025. At: https://www.health.gov.au/resources/publications/government-response-to-inquiry-issues-related-to-menopause-and-perimenopause
  16. Butler M, White R. Women’s health package delivers [media release]. Canberra: Australian Government Department of Health and Aged Care. 2026. At: https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/womens-health-package-delivers
  17. Australasian Menopause Society. Testosterone therapy in postmenopausal women: evidence, efficacy, and safety. AMS Hub. At: https://hub.menopause.org.au/Play?pId=30177c59-b317-416c-bb2c-b4553114983e
  18. Australasian Menopause Society. Complementary medicines and therapies: options for menopausal symptoms. AMS Hub. At: https://hub.menopause.org.au/Play?pId=3234710f-e5db-4aa1-bff8-ae98449fffad